erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
december 2007 (18).
copyright 2018 npr. to see more, visit /www.npr.org/..